M. Kulyk & Associates’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.5M Buy
46,067
+3,216
+8% +$422K 1.03% 34
2025
Q4
$5.84M Buy
42,851
+2,374
+6% +$341K 1.12% 35
2025
Q3
$5.97M Sell
40,477
-1,549
-4% -$215K 1.21% 31
2025
Q2
$5.44M Buy
42,026
+1,205
+3% +$146K 1.18% 30
2025
Q1
$4.88M Buy
40,821
+596
+1% +$73.9K 1.12% 33
2024
Q4
$4.67M Sell
40,225
-1,888
-4% -$239K 1.01% 35
2024
Q3
$5.69M Buy
42,113
+216
+0.5% +$28.9K 1.14% 31
2024
Q2
$5.68M Sell
41,897
-1,144
-3% -$156K 1.32% 27
2024
Q1
$5.56M Sell
43,041
-1,437
-3% -$174K 1.29% 31
2023
Q4
$5.09M Buy
44,478
+3,312
+8% +$331K 1.18% 35
2023
Q3
$3.75M Sell
41,166
-232
-0.6% -$23.9K 1.04% 35
2023
Q2
$4.66M Sell
41,398
-1,063
-3% -$112K 1.3% 30
2023
Q1
$4.45M Buy
42,461
+1,014
+2% +$106K 1.35% 31
2022
Q4
$4.58M Buy
41,447
+138
+0.3% +$14.5K 1.53% 25
2022
Q3
$3.61M Sell
41,309
-15,592
-27% -$1.42M 1.25% 32
2022
Q2
$4.45M Buy
56,901
+5,251
+10% +$434K 1.38% 28
2022
Q1
$4.4M Buy
51,650
+9,093
+21% +$871K 1.2% 34
2021
Q4
$5.1M Buy
42,557
+2,934
+7% +$364K 1.32% 34
2021
Q3
$4.9M Buy
39,623
+1,053
+3% +$136K 1.57% 24
2021
Q2
$4.63M Sell
38,570
-1,092
-3% -$125K 1.67% 26
2021
Q1
$4.17M Buy
39,662
+2,445
+7% +$248K 1.56% 25
2020
Q4
$3.79M Buy
+37,217
New +$3.5M 2.1% 9

Other funds holding XYL

M. Kulyk & Associates's XYL Position: Q1 2026 in Review

M. Kulyk & Associates increased its Xylem (XYL) stake by 7.5% in Q1 2026, buying an estimated $422K and bringing the position to 46,067 shares worth $5.5M. The position accounts for 1.03% of the portfolio, ranked #34.

M. Kulyk & Associates first reported a position in XYL in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.97M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • M. Kulyk & Associates held 46,067 shares of Xylem worth $5.5M as of Q1 2026.
  • M. Kulyk & Associates bought 3,216 Xylem shares in Q1 2026, an estimated $422K.
  • Xylem made up 1.03% of M. Kulyk & Associates's portfolio in Q1 2026, its #34 holding.
  • M. Kulyk & Associates first reported a position in Xylem in Q4 2020 and has held it in 22 quarters since.
  • M. Kulyk & Associates's Xylem position peaked at $5.97M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on M. Kulyk & Associates's 13F filing for Q1 2026, filed 6 May 2026.